Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma

REFERENCES

• Kongsbak M, Levring TB, Geisler C, and von Essen MR: The vitamin d receptor and T cell function. Front Immunol 4, 148, 2013. doi:10.3389/fimmu.2013.00148
   PubMed Web of Science ®Google Scholar
• Zerwekh JE: Blood biomarkers of vitamin D status. Am J Clin Nutr 87, 1087S–1091S, 2008.
   PubMed Web of Science ®Google Scholar
• Nemazannikova N, Antonas K, and Dass CR: Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies. Mol Carcinog 53, 421–431, 2013. doi:10.1002/mc.21999
   PubMed Web of Science ®Google Scholar
• Diesel B, Radermacher J, Bureik M, Bernhardt R, Seifert M, et al.: Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res 11, 5370–5380, 2005. doi:10.1158/1078-0432.CCR-04-1968
   PubMed Web of Science ®Google Scholar
• Elias J, Marian B, Edling C, Lachmann B, Noe CR, et al.: Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res 164, 319–332, 2003.
   PubMedGoogle Scholar
• Hansen CM, Binderup L, Hamberg KJ, and Carlberg C: Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 6, D820–D848, 2001.
   PubMed Web of Science ®Google Scholar
• Kyritsis AP, Bondy ML, and Levin VA: Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents. Nutr Cancer 63, 174–184, 2011. doi:10.1080/01635581.2011.523807
   PubMed Web of Science ®Google Scholar
• Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, and Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13, 100–105, 2002.
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Pizot C, and Mullie P: Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2, 76–89, 2014. doi:10.1016/S2213-8587(13)70165-7
   PubMed Web of Science ®Google Scholar
• Toner CD, Davis CD, and Milner JA: The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc 110, 1492–1500, 2010. doi: 10.1016/j.jada.2010.07.007
   PubMed Web of Science ®Google Scholar
• Yin L, Ordonez-Mena JM, Chen T, Schottker B, Arndt V, et al.: Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: A systematic review and meta-analysis. Prev Med 57, 753–764, 2013. doi:10.1016/j.ypmed.2013.08.026
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Grey A, Gamble GD, and Reid IR: The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2, 307–320, 2014. doi:10.1016/S2213-8587(13)70212-2
   PubMed Web of Science ®Google Scholar
• Gille O: Controlled trials of vitamin D, causality and type 2 statistical error. Public Health Nutrition 349, 1–12, 2014.
   Web of Science ®Google Scholar
• Afzal S, Brondum-Jacobsen P, Bojesen SE, and Nordestgaard BG: Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts. BMJ 349, g6330, 2014. doi:10.1136/bmj.g6330
   PubMed Web of Science ®Google Scholar
• Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, et al.: Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 204, 13–18, 2011. doi: S0165-4608(10)00557-1
   PubMed Web of Science ®Google Scholar
• Koshy M, Villano JL, Dolecek TA, Villano JL, Howard A, et al.: Improved survival time trends for glioblastoma using the SEER population-based registries. J Neurooncol 107, 207–212, 2012.
   PubMed Web of Science ®Google Scholar
• Stumpf WE: Drugs in the brain—cellular imaging with receptor microscopic autoradiography. Prog Histochem Cytochem 47, 1–26, 2012. doi:10.1016/j.proghi.2011.12.001
   PubMed Web of Science ®Google Scholar
• Eyles DW, Liu PY, Josh P, and Cui X: Intracellular distribution of the vitamin D receptor in the brain: Comparison with classic target tissues and redistribution with development. Neuroscience 268, 1–9, 2014. doi:10.1016/j.neuroscience.2014.02.042
   PubMed Web of Science ®Google Scholar
• Chun RF, Liu PT, Modlin RL, Adams JS, and Hewison M: Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol 5, 151, 2014. doi:10.3389/fphys.2014.00151
   PubMed Web of Science ®Google Scholar
• Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, et al.: Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 104, 1251–1259, 2012. doi:10.1093/jnci/djs315
   PubMed Web of Science ®Google Scholar
• Wei J, Barr J, Kong LY, Wang Y, Wu A, et al.: Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res 16, 461–473, 2010. doi:10.1158/1078-0432.CCR-09-1983
   PubMed Web of Science ®Google Scholar
• Brustad M, Sandanger T, Aksnes L, and Lund E: Vitamin D status in a rural population of northern Norway with high fish liver consumption. Public Health Nutr 7, 783–789, 2004.
   PubMed Web of Science ®Google Scholar
• Holvik K, Brunvand L, Brustad M, Meyer HE: Vitamin D status in the Norwegian population. In: Solar Radiation and Human Health, Bjertness E (ed.). Oslo, Norway: The Norwegian Academy of Science and Letters, 2008, pp. 216–228.
   Google Scholar
• Christensen MH, Lien EA, Hustad S, and Almas B: Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scand J Clin Lab Invest 70, 281–286, 2010. doi:10.3109/00365511003797172
   PubMed Web of Science ®Google Scholar
• Vieth R, Cole DE, Hawker GA, Trang HM, and Rubin LA: Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 55, 1091–1097, 2001. doi:10.1038/sj.ejcn.1601275
   PubMed Web of Science ®Google Scholar
• Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, et al.: Vitamin D status: United States, 2001–2006. NCHS Data Brief 59, 1–8, 2011.
   PubMedGoogle Scholar
• Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, and Orjasaeter H: The JANUS serum bank. Sci Total Environ 139–140, 527–535, 1993.
   PubMed Web of Science ®Google Scholar
• Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, and Orjasaeter H: Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 103(Suppl 3), 85–88, 1995.
   PubMed Web of Science ®Google Scholar
• Langseth H, Gislefoss R, Martinsen JI, Stornes A, Lauritzen M, et al.: The Janus Serum Bank:From sample collection to cancer research. Oslo, Norway: Cancer Registry of Norway, 2009.
   Google Scholar
• Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, et al.: The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione. Nutr Cancer 62, 51–57, 2010. doi:10.1080/01635580903191460
   PubMed Web of Science ®Google Scholar
• Bodnar LM, Catov JM, Wisner KL, and Klebanoff MA: Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 101, 278–284, 2009. doi:10.1017/S0007114508981460
   PubMed Web of Science ®Google Scholar
• Helgesson G, Dillner J, Carlson J, Bartram CR, Hansson MG: Ethical framework for previously collected biobank samples. Nat Biotechnol 25, 973–976, 2007. doi:10.1038/nbt0907-973b
   PubMed Web of Science ®Google Scholar
• Bozdag S, Li A, Riddick G, Kotliarov Y, Baysan M, et al.: Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels. PLoS ONE 8, e62982, 2013. doi:10.1371/journal.pone.0062982
   PubMed Web of Science ®Google Scholar
• Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, et al.: Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 100, 796–804, 2008. doi:10.1093/jnci/djn152
   PubMed Web of Science ®Google Scholar
• Vinceti M, Malagoli C, Fiorentini C, Longo C, Crespi CM, et al.: Inverse association between dietary vitamin D and risk of cutaneous melanoma in a northern Italy population. Nutr Cancer 63, 506–513, 2011. doi:10.1080/01635581.2011.539314
   PubMed Web of Science ®Google Scholar
• Crane JF and Trainor PA: Neural crest stem and progenitor cells. Annual Review of Cell and Developmental Biology 22, 267–286, 2006.
   PubMed Web of Science ®Google Scholar
• Scarbrough PM, Akushevich I, Wrensch M, and Il'yasova D: Exploring the association between melanoma and glioma risks. Ann Epidemiol 24, 469–474, 2014. doi:10.1016/j.annepidem.2014.02.010
   PubMed Web of Science ®Google Scholar
• Scheurer ME, Etzel CJ, Liu M, Barnholtz-Sloan J, Wiklund F, et al.: Familial aggregation of glioma: a pooled analysis. Am J Epidemiol 172, 1099–1107, 2010. doi:10.1093/aje/kwq261
   PubMed Web of Science ®Google Scholar
• Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, et al.: TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961, 2013. doi:10.1126/science.1230062
   PubMed Web of Science ®Google Scholar
• Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, et al.: Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959, 2013. doi:10.1126/science.1229259
   PubMed Web of Science ®Google Scholar
• Walsh KM, Rice T, Decker PA, Kosel ML, Kollmeyer T, et al.: Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol 15, 1041–1047, 2013. doi:10.1093/neuonc/not051
   PubMed Web of Science ®Google Scholar
• Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, et al.: TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110, 6021–6026, 2013. doi:10.1073/pnas.1303607110
   PubMed Web of Science ®Google Scholar
• Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, et al.: Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol 126, 907–15, 2013. doi:10.1007/s00401-013-1195-5
   PubMed Web of Science ®Google Scholar
• Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, et al.: The somatic genomic landscape of glioblastoma. Cell 155, 462–477, 2013. doi:10.1016/j.cell.2013.09.034
   PubMed Web of Science ®Google Scholar
• Arita H, Narita Y, Takami H, Fukushima S, Matsushita Y, et al.: TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas. Acta Neuropathol 126, 939–941, 2013. doi:10.1007/s00401-013-1203-9
   Web of Science ®Google Scholar
• Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, et al.: MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. J Steroid Biochem Mol Biol 138, 427–434, 2013. doi:10.1016/j.jsbmb.2013.09.002
   PubMed Web of Science ®Google Scholar
• Jiang F, Bao J, Li P, Nicosia SV, and Bai W: Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 279, 53213–53221, 2004. doi:10.1074/jbc.M410395200
   PubMed Web of Science ®Google Scholar
• Kasiappan R, Shen Z, Tse AK, Jinwal U, Tang J, et al.: 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. J Biol Chem 287, 41297–41309, 2012. doi:10.1074/jbc.M112.407189
   PubMed Web of Science ®Google Scholar
• Shay JW and Wright WE: Role of telomeres and telomerase in cancer. Semin Cancer Biol 21, 349–353, 2011. doi:10.1016/j.semcancer.2011.10.001
   PubMed Web of Science ®Google Scholar
• Rubis B, Holysz H, Gladych M, Toton E, Paszel A, et al.: Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner. Mol Biol Rep 40, 4995–5004, 2013. doi:10.1007/s11033-013-2600-9
   PubMed Web of Science ®Google Scholar
• Correale J, Ysrraelit MC, and Gaitan MI: Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185, 4948–4958, 2010. doi:10.4049/jimmunol.1000588
   PubMed Web of Science ®Google Scholar
• Kuhn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, et al.: Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int J Cancer 133, 1689–1700, 2013. doi:10.1002/ijc.28172
   PubMed Web of Science ®Google Scholar
• Rosario ER, Chang L, Head EH, Stanczyk FZ, and Pike CJ: Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 32, 604–613, 2011. doi:10.1016/j.neurobiolaging.2009.04.008
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Kaufman JM, Goemaere S, and van Pottelberg I: Estradiol in elderly men. Aging Male 5, 98–102, 2002.
   PubMedGoogle Scholar
• Lin JH, Zhang SM, Rexrode KM, Manson JE, Chan AT, et al.: Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol 11, 419–424, 2013. doi:10.1016/j.cgh.2012.11.012
   PubMed Web of Science ®Google Scholar
• Johann S and Beyer C: Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J Steroid Biochem Mol Biol 137, 71–81, 2013. doi:10.1016/j.jsbmb.2012.11.006
   PubMed Web of Science ®Google Scholar
• Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, and Moan J: The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 29, 3713–3720, 2009.
   PubMed Web of Science ®Google Scholar
• Jurek AM, Greenland S, and Maldonado G: How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null? Int J Epidemiol 37, 382–385, 2008. doi:10.1093/ije/dym291
   PubMed Web of Science ®Google Scholar
• Qi ZY, Shao C, Zhang X, Hui GZ, and Wang Z: Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS ONE 8, e68695, 2013. doi:10.1371/journal.pone.0068695
   PubMed Web of Science ®Google Scholar